Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Acta Paediatrica (Oslo, Norway : 1992)
|
November 24, 1998
Port-A-Cath usage in children with haemophilia: experience of 53 cases
R Ljung, M van den Berg, P Petrini, et al.
Clinical Genetics
|
October 27, 1998
Three novel PROC gene lesions causing protein C deficiency
P J Hallam, P Mannucci, A Tripodi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 21, 2012
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry
L Tengborn, F Baudo, A Huth-Kühne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2004
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden
K Steen Carlsson, S Höjgård, A Lindgren, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 27, 2003
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome
K Steen Carlsson, S Höjgård, A Glomstein, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 11, 2012
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P Knoebl, P Marco, F Baudo, et al.
Lakartidningen
|
May 13, 1999
[Centralized care is the basis of care programs for hemophilia patients]
E Berntorp, S Lethagen, R Ljung, et al.
Thrombosis and Haemostasis
|
February 1, 1997
Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients
K Fijnvandraat, E Berntorp, J W ten Cate, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 10, 2001
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients
E Berntorp, P Petrini, G Dockter, et al.
Seminars in Hematology
|
December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
M C Poon, R d'Oiron, I Hann, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Acta Paediatrica (Oslo, Norway : 1992)
|
November 24, 1998
Port-A-Cath usage in children with haemophilia: experience of 53 cases
R Ljung, M van den Berg, P Petrini, et al.
Clinical Genetics
|
October 27, 1998
Three novel PROC gene lesions causing protein C deficiency
P J Hallam, P Mannucci, A Tripodi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 21, 2012
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry
L Tengborn, F Baudo, A Huth-Kühne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2004
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden
K Steen Carlsson, S Höjgård, A Lindgren, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 27, 2003
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome
K Steen Carlsson, S Höjgård, A Glomstein, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 11, 2012
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P Knoebl, P Marco, F Baudo, et al.
Lakartidningen
|
May 13, 1999
[Centralized care is the basis of care programs for hemophilia patients]
E Berntorp, S Lethagen, R Ljung, et al.
Thrombosis and Haemostasis
|
February 1, 1997
Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients
K Fijnvandraat, E Berntorp, J W ten Cate, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 10, 2001
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients
E Berntorp, P Petrini, G Dockter, et al.
Seminars in Hematology
|
December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
M C Poon, R d'Oiron, I Hann, et al.
Page
of 10